(Q54275922)

27 May 2018

title

Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)81228-4

12 November 2022

1 reference

V. K. Bhutani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735846

12 November 2022

S. Abbasi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735846

12 November 2022

W. A. Long

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735846

12 November 2022

J. S. Gerdes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735846

12 November 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

27 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0022347605812284?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)81228-4

https://api.elsevier.com/content/article/PII:S0022347605812284?httpAccept=text/plain

12 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)81228-4

The Journal of Pediatrics

12 November 2022

published in

1 reference

27 May 2018

volume

120

1 reference

27 May 2018

issue

2 Pt 2

1 reference

27 May 2018

page(s)

S18-24

1 reference

27 May 2018

Permeability of premature lamb lungs to protein and the effect of surfactant on that permeability

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Leakage of protein in the immature rabbit lung; effect of surfactant replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Prophylactic treatment of very premature infants with human surfactant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Effects of artificial surfactant on lung function and blood gases in idiopathic respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Effect of exogenous surfactant on total respiratory system compliance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Duration and characteristics of treatment of premature lambs with natural surfactant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Evaluation of neonatal pulmonary mechanics and energetics: a two factor least mean square analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Chestwall compliance in full-term and premature infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Influence of chest wall distortion on esophageal pressure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Distortion of chest wall and work of diaphragm in preterm infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Noninvasive determination of respiratory mechanics during mechanical ventilation of neonates: a review of current and future techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Effect of spontaneous and mechanical breathing on dynamic lung mechanics in hyaline membrane disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Pulmonary mechanics in normal infants and young children during first 5 years of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Pulmonary mechanics and energetics of normal, non-ventilated low birthweight infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Pulmonary function in the sick newborn infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

Effect of single dose surfactant on pulmonary function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981228-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants

5

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)81228-4

Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease

12 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)81228-4

12 November 2022

Identifiers

1 reference

27 May 2018

1 reference

27 May 2018